European countries are better than the USA in optimizing the care of patients with axial spondyloarthritis (axSpA). The data comes from international surveys collected from doctors and patients in the US and five European countries. Surveys indicate that European care is more effective in treating this disease. Axial spondyloarthritis is an inflammatory disease affecting the spine. The study compared treatment outcomes between these regions. Europe achieves better results in symptom management and patient quality of life. The data support the priority of European procedures in clinical practice.